Britain's NHS Test and Trace reducing size of contact tracing workforce

© Reuters. FILE PHOTO: A government and NHS Test and Trace advert is seen on a billboard in London

By Kanishka Singh

(Reuters) – Britain’s NHS (National Health Service) Test and Trace system is reducing the size of its contact tracing workforce after a decline in coronavirus cases in the country.

“Just as we increased numbers working in the trace service over the winter, we are now responding to the reduction in case numbers we’ve seen this spring”, a spokeswoman for the Department for Health and Social Care said in an emailed statement on Friday.

“We are continuing to respond to changes in demand and reflect staff numbers accordingly”, the statement added.

The statement did not specify by how much the staff is being reduced. It said that NHS Test and Trace has contacted almost 10 million people since it began.

A total of more than 34.2 million people in Britain have been given a first dose of COVID-19 vaccine, government statistics showed on Friday. A further 2,381 people had tested positive for the virus, down slightly on the day before.

There were 15 new deaths recorded within 28 days of a positive test, compared to the 22 deaths recorded on Thursday.

Earlier in April, Britain’s health ministry said there were no plans to halt rapid coronavirus testing.

Britain will buy 60 million more doses of Pfizer/BioNTech’s, vaccine, health minister Matt Hancock said earlier this week, in a deal that more than doubles the country’s supply of the shot ahead of a booster programme later this year.

Britain has now ordered a total of 100 million doses of the Pfizer (NYSE:) vaccine, one of three COVID-19 shots being rolled out in the country.

READ  Face-to-face but not elbow-to-elbow, Britain's cabinet returns

Britain, which has a population of 67 million, has deals for 517 million doses of eight different COVID-19 vaccines, some of which remain under development.

Disclaimer: Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. All CFDs (stocks, indexes, futures) and Forex prices are not provided by exchanges but rather by market makers, and so prices may not be accurate and may differ from the actual market price, meaning prices are indicative and not appropriate for trading purposes. Therefore Fusion Media doesn`t bear any responsibility for any trading losses you might incur as a result of using this data.

Fusion Media or anyone involved with Fusion Media will not accept any liability for loss or damage as a result of reliance on the information including data, quotes, charts and buy/sell signals contained within this website. Please be fully informed regarding the risks and costs associated with trading the financial markets, it is one of the riskiest investment forms possible.



Please enter your comment!
Please enter your name here